Melan-A, MART-1 (27-35) – 1 mg

Overview

Melan-A, MART-1 (27-35) is a peptide essential for research in immunotherapy and melanoma studies. Recognized as a melanocyte differentiation antigen, this peptide plays a crucial role in the immune response against melanoma cells. The sequence is a naturally occurring nonamer peptide recognized by cytotoxic T lymphocytes (TILs). Melanocytes express the Melan-A/MART-1 gene, which is present in most melanoma samples and cell lines. This feature makes it a vital component for scientists and researchers working in the field of cancer immunotherapy.

Key Features

• Recognized by cytotoxic T lymphocytes (TILs)
• Expressed by normal melanocytes and melanoma cells
• Critical for developing immunotherapeutic strategies
• Available in a 1 mg quantity for diverse research applications
• Facilitates studies on HLA-A2-restricted melanoma-specific responses

Specifications

FAQ

What is Melan-A, MART-1 (27-35) used for?

This peptide is primarily used in cancer research, particularly in investigating immune responses against melanoma. It helps in developing immunotherapeutic strategies.

How is the quality of Melan-A ensured?

Our Melan-A, MART-1 (27-35) is synthesized under stringent quality controls, ensuring high purity and biological activity suitable for research applications.

Can this peptide be used for in vivo studies?

While primarily used for in vitro studies, consult relevant protocols for dosing and administration in in vivo models.

For further research and application in peptide synthesis, consider exploring our other peptides such as Autocamtide-2 and CREBtide. Each peptide offers unique properties suited for a variety of experimental needs. Shop now and enhance your research with quality peptides from AnaSpec.

Related Products

• PKG Substrate [RKRSRAE], Glasstide

Browse more in Peptides.